Localization and treatment of transformed tissues using the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a
- PMID: 8833284
- DOI: 10.1002/(SICI)1096-9101(1996)18:2<157::AID-LSM5>3.0.CO;2-R
Localization and treatment of transformed tissues using the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a
Abstract
Background and objective: Photofrin is the photosensitizer currently used in most clinical trials examining the efficacy of photodynamic therapy (PDT) for the treatment and/or palliation of neoplasia. Although this drug has been shown to be efficacious in many of these trials, it possesses less than ideal qualities for use in a systemically administered photosensitizer. A new photosensitizer, 2-[l-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH), was developed for PDT. HPPH possesses more rapid clearance from skin and greater cytotoxicity per drug dose than Photofrin. The aims of this study were to: (1) examine the uptake and retention of HPPH in tissues undergoing malignant transformation using laser-induced fluorescence, and (2) evaluate the efficacy of HPPH and 665 nm light in treating carcinogen-induced tumors of the hamster buccal cheek pouch.
Study design/materials and methods: The model of tissue transformation was the carcinogen (9,10-dimethyl-1, 2-benzanthracene)-induced premalignant and malignant lesions of the hamster buccal cheek pouch. Following induction of the specific transformation stages, hamsters were injected intraperitoneally with 0.5 mg/kg HPPH. Subsequently, the buccal mucosa was examined for fluorescence at various times up to 72 hours after photosensitizer injection.
Results: Uptake studies of HPPH showed highest fluorescence levels in tissues 48 hours after HPPH injection. Fluorescence levels of tissues increased significantly as follows. Normal < dysplasia < papillomas < squamous cell carcinomas. Carcinogen-induced tumors in 14 hamsters were treated with surface illuminations of red light (665 nm) via fiber optics coupled to an argon-ion pumped dye laser 48 hours after intraperitoneal injection with either 0.5 or 1.0 mg/kg HPPH. Complete necrosis of tumor tissues 7 days following PDT was observed in 57% (4/7) with 0.5 mg/kg and 86% (6/7) with 1.0 mg/kg HPPH.
Similar articles
-
Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.Cancer Res. 2003 Apr 15;63(8):1806-13. Cancer Res. 2003. PMID: 12702566
-
Photodynamic therapy for premalignant lesions in DMBA-treated hamsters: a preliminary study.J Oral Maxillofac Surg. 1997 Apr;55(4):376-81; discussion 381-2. doi: 10.1016/s0278-2391(97)90130-0. J Oral Maxillofac Surg. 1997. PMID: 9120701
-
2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapy.Lasers Surg Med. 2001;29(5):397-405. doi: 10.1002/lsm.10001. Lasers Surg Med. 2001. PMID: 11891727
-
Mesoscopic fluorescence tomography of a photosensitizer (HPPH) 3D biodistribution in skin cancer.Acad Radiol. 2014 Feb;21(2):271-80. doi: 10.1016/j.acra.2013.11.009. Acad Radiol. 2014. PMID: 24439340 Review.
-
Endobronchial photodynamic therapy for lung cancer.Lasers Surg Med. 2006 Jun;38(5):364-70. doi: 10.1002/lsm.20354. Lasers Surg Med. 2006. PMID: 16788932 Review.
Cited by
-
Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo.Cancer Res. 2001 Jun 1;61(11):4490-6. Cancer Res. 2001. PMID: 11389080 Free PMC article.
-
Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy.Lasers Surg Med. 2011 Sep;43(7):686-95. doi: 10.1002/lsm.21113. Lasers Surg Med. 2011. PMID: 22057496 Free PMC article.
-
Efficacy of 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a in photodynamic therapy of human esophageal squamous cancer cells.Oncol Lett. 2013 Oct;6(4):1111-1119. doi: 10.3892/ol.2013.1493. Epub 2013 Jul 25. Oncol Lett. 2013. PMID: 24137473 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources